Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06380569 · ClinicalTrials.gov registry record · NA

A Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community Setting

A NA study of Autism Spectrum Disorder, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06380569: Recruiting NA study of Autism Spectrum Disorder, sponsored by Kessler Foundation.

NCT06380569 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 30 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06380569, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators are looking to evaluate how effective a strength-based intervention may be in improving job interview skills in young adults. The investigators are examining the effects of this intervention in young adults who may have difficulty with job interviews, and who may want to improve these skills.

Conditions Studied

Interventions

  • BEHAVIORAL KF-STRIDE®

Study Locations (1)

New Jersey

  • Kessler Foundation - East Hanover

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-07-01
Est. Completion 2025-12-01
Phase NA
Kessler Foundation

104 total trials

What NCT06380569 shows while recruiting

NCT06380569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which KF-STRIDE® is the first listed.

NCT06380569 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06380569 about?

NCT06380569 is a clinical study titled "A Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community Setting". The investigators are looking to evaluate how effective a strength-based intervention may be in improving job interview skills in young adults. The investigators are examining the effects of this intervention in young adults who may have difficulty with job interviews, and who may want to improve th...

What is the current status of trial NCT06380569?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-07-01. Estimated completion is 2025-12-01.

What conditions does trial NCT06380569 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06380569?

The interventions under investigation include: KF-STRIDE® (BEHAVIORAL).

Who is sponsoring clinical trial NCT06380569?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06380569 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06380569's enrollment target sits among peer trials

30 170th of 224 higher than 50 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06380569, the US trial registry maintained by the National Library of Medicine. NCT06380569 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.